ClinicalTrials.Veeva

Menu

Anatomical Scale for the Prognosis of Fournier Syndrome.

I

Instituto Mexicano del Seguro Social

Status and phase

Completed
Phase 3

Conditions

Fournier's Gangrene

Treatments

Procedure: reconstructive technique

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Type of study: Case series. Universe of study: Records of patients with Fournier syndrome treated using the 3-stage reconstructive technique assigned and treated at the Mexican Social Security Institute: Regional General Hospital No. 1 of Mérida, Yucatán, during the years 2021-2024.

Population under study: Patients diagnosed with Fournier syndrome.

Full description

The first surgical stage consists of damage limitation and extension analysis. In the second surgical stage, it was necessary to wash and prepare the area to be remodeled with the joint creation of the testicular resting space delimited by the fascia of the adductor muscles of the proximal lower limb. Finally, in the third surgical stage, the wound is remodeled and addressed. The surgery was performed in patients with extensive involvement that could not be resolved with minor surgery.

The 3-stage reconstructive technique can be summarized as follows:

  1. Analysis and limitation of the tissue injury. Bilateral testicular and spermatic cord dissection.
  2. Formation of cutaneous flaps and bilateral inguinal neocavity.
  3. Perineal-scrotal reconstruction with fascial facing and cutaneous flaps

Enrollment

58 patients

Sex

Male

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients diagnosed with perineal necrotizing fasciitis (Fournier syndrome), at the General Hospital Zone No. 1, aged between 40-85 years, who have undergone surgery

Exclusion criteria

  • Those who could not be followed up due to incomplete records. Those who did not complete the three procedures due to mortality associated with primary pathologies independent of necrotizing fasciitis.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems